Beyond quality of life: A call for patients' own willingness to pay in chronic skin disease to assess psychosocial burden—A multicenter, cross-sectional, prospective survey-Reference-Cited by-同舟云学术

Beyond quality of life: A call for patients' own willingness to pay in chronic skin disease to assess psychosocial burden—A multicenter, cross-sectional, prospective survey

Published:2021-11 Issue:5 Volume:85 Page:1321-1324
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Bae Jung Min,Kim Jung Eun,Lee Ro Woo,Ju Hyun Jeong,Han Ju Hee,Lee Joo Hee,Woo Yu Ri,Lee Ji Hae,Bang Chul Hwan,Park Chul Jong,Ezzedine Khaled,Kim Miri

Publisher

Elsevier BV

Subject

Dermatology

Reference5 articles.

1. Preference-based measures in dermatology: an overview of utilities and willingness to pay;Seidler;Dermatol Clin,2012

2. Willingness to pay and quality of life in alopecia areata;Okhovat;J Am Acad Dermatol,2017

3. Is the DLQI appropriate for medical decision-making in psoriasis patients?;Poor;Arch Dermatol Res,2018

4. Willingness-to-pay and quality of life in patients with vitiligo;Radtke;Br J Dermatol,2009

5. Discrepancies between the Dermatology Life Quality Index and utility scores;Rencz;Qual Life Res,2016

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NAcM‐OPT protects keratinocytes from H₂O₂‐induced cell damage by promoting autophagy;Annals of the New York Academy of Sciences;2024-06-22

2. Vitiligo: A Patch on Skin and the Mind;Critical Thinking in Contemporary Dermatology: Cognitive Essays;2024

3. Psychological Burden and Willingness to Pay Among Korean Rosacea Patients and Their Association With Rosacea Phenotype and Severity: A Multi-Center Cross-Sectional Study;Journal of Cutaneous Medicine and Surgery;2023-08-17

4. Exploring the natural and treatment history of vitiligo: perceptions of patients and healthcare professionals from the global VALIANT study;British Journal of Dermatology;2023-07-26

5. Treatment update for vitiligo based on autoimmune inhibition and melanocyte protection;Expert Opinion on Therapeutic Targets;2023-03-04